Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Conventional and Genetic Evidence on the Association between Adiposity and CKD.

Zhu P. et al, (2020), J Am Soc Nephrol

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Levin A. et al, (2020), Kidney International, 98, 849 - 859

Pre-randomization run-in periods in randomized controlled trials of chronic diseases: a methodological study.

Collister D. et al, (2020), J Clin Epidemiol

CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE

HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology

Association of Blood Pressure With Cause-Specific Mortality in Mexican Adults.

Tapia-Conyer R. et al, (2020), JAMA Netw Open, 3

Blood pressure and kidney disease: chicken or egg (or both)?

Staplin N. et al, (2020), Kidney Int, 98, 547 - 549

In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.

Herrington WG. and Staplin N., (2020), Ann Intern Med, 173

In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.

Herrington WG. and Staplin N., (2020), Ann Intern Med, 173

Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.

Herrington WG. et al, (2020), Clin Kidney J, 13

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank.

Zhu P. et al, (2020), Int J Obes (Lond)

Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop

O'Lone E. et al, (2020), American Journal of Kidney Diseases, 76, 109 - 120

Haemodialysis, blood pressure and risk: at the limit of non-randomized evidence.

Ng SYA. et al, (2020), Nephrol Dial Transplant

In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.

Ai Ng SY. et al, (2020), Ann Intern Med, 172

Accelerometer-measured physical activity and functional behaviours among people on dialysis

Nawab K. et al, (2020), Clinical Kidney Journal

Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals.

O'Lone E. et al, (2020), Nephrol Dial Transplant

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.

Lamprea-Montealegre JA. et al, (2019), Clin J Am Soc Nephrol

Kidney disease trials for the 21st century: innovations in design and conduct.

Herrington WG. et al, (2019), Nat Rev Nephrol

Body composition and mortality from vascular or metabolic causes among 150,000 participants in the Mexico City Prospective Study

Gnatiuc L. et al, (2019), EUROPEAN HEART JOURNAL, 40, 2412 - 2412

General and Abdominal Adiposity and Mortality in Mexico City: A Prospective Study of 150 000 Adults.

Gnatiuc L. et al, (2019), Ann Intern Med, 171, 397 - 405

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.

Schlackow I. et al, (2019), Kidney Int, 96, 170 - 179

Load More

1
2
3
4
5
6

Include forthcoming?